NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MindRank

MindRank

Private
HangzhouHealthcare & Life Scienceshttps://www.mindrank.ai/en

Last Round

Series B

Jul 10, 2026

Total Funding Raised

$82M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

MindRank is a clinical-stage drug discovery company that uses its proprietary artificial intelligence (AI) platforms to accelerate the development of small molecule medicines.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

AI drug discoverydrug discovery platformsmall molecule drug discoveryclinical-stage biotechin silico drug discoveryAI biotechhard-to-drug targetsDesign as a Servicedrug discovery servicesgenerative AI drug discoverymolecular dynamics simulationbiomedical knowledge graphGLP-1 agonistobesity drug developmentpreclinical candidate deliverydrug discovery CRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MindRank Comparables

Compare MindRank with similar companies based on industry and business-model similarity.

MindRank comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genesis Molecular AI
87%
Galixir
85%
Guangzhou Fermion Technology Co., Ltd.
85%

MindRank Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 10, 2026
Series A ExtensionJul 18, 2023
Series ADec 16, 2021
SeedMay 21, 2021

Key People

Founding team and executive leadership

Zhangming N.

Founder & CEO

Founding Team

MindRank Investors

Notable investors and investment history

MindRank investors
InvestorRounds
Huagai CapitalSeries A
Sherpa Healthcare PartnersSeries A, Seed
松禾资本 (Green Pine Capital Partners)Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2026

    Open roles increased to 30, 150% of headcount.

  • Jul 10, 2026

    $52M round completed.

MindRank Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MindRank Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MindRank's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range20
Year Founded2020
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.